Background: The g-tubulin ring complex (gTuRC) is a multisubunit complex responsible for microtubule (MT) nucleation in eukaryotic cells. During mitosis, its spatial and temporal regulation promotes MT nucleation through different pathways. One of them is triggered around the chromosomes by RanGTP. Chromosomal MTs are essential for functional spindle assembly, but the mechanism by which RanGTP activates MT nucleation has not yet been resolved. Results: We used a combination of Xenopus egg extracts and in vitro experiments to dissect the mechanism by which RanGTP triggers MT nucleation. In egg extracts, NEDD1-coated beads promote MT nucleation only in the presence of RanGTP. We show that RanGTP promotes a direct interaction between one of its targets, TPX2, and XRHAMM that defines a specific gTuRC subcomplex. Through depletion/add-back experiments using mutant forms of TPX2 and NEDD1, we show that the activation of MT nucleation by RanGTP requires both NEDD1 phosphorylation on S405 by the TPX2-activated Aurora A and the recruitment of the complex through a TPX2-dependent mechanism. Conclusions: The XRHAMM-gTuRC complex is the target for activation by RanGTP that promotes an interaction between TPX2 and XRHAMM. The resulting TPX2-RHAMM-gTuRC supracomplex fulfills the two essential requirements for the activation of MT nucleation by RanGTP: NEDD1 phosphorylation on S405 by the TPX2-activated Aurora A and the recruitment of the complex onto a TPX2-dependent scaffold. Our data identify TPX2 as the only direct RanGTP target and NEDD1 as the only Aurora A substrate essential for the activation of the RanGTP-dependent MT nucleation pathway.
Introduction
During mitosis, different microtubule (MT) nucleation pathways drive the assembly of dynamic MTs to organize a bipolar spindle [1] . One of them relies on a gradient of guanosine triphosphate (GTP)-bound Ran (RanGTP) centered on the chromosomes that promotes the dissociation of nuclear localization signal (NLS)-containing proteins from karyopherins and drives MT nucleation, stabilization, and organization [2] . Several spindle assembly factors have been identified as direct targets of RanGTP during mitosis [3] [4] [5] [6] . However, the precise role of these factors in chromosomal-dependent MT assembly is still in many cases ill defined, and we therefore still do not understand the mechanism at play. Because these MTs are essential for building a functional bipolar spindle whether centrosomes are present or not [7] , understanding this pathway is essential to fully understand cell division.
In higher eukaryotic cells, MT nucleation relies on the g-tubulin ring complex (gTuRC), a multisubunit complex constituted by multiple copies of g-tubulin and a number of associated proteins called gamma tubulin complex proteins (GCPs) [8, 9] . The gTuRC and its adaptor protein NEDD1 are required for all the known pathways of MT nucleation in animal mitosis [10, 11] . These pathways are defined spatially in the mitotic cell by occurring at the centrosomes, on preexisting MTs, and around the chromosomes. Work from different groups has shown that an important target for gTuRC regulation in mitosis is NEDD1 through its phosphorylation by different kinases [12] [13] [14] [15] . We recently showed that chromosomal MT assembly requires NEDD1 phosphorylation on S405 by Aurora A [16] .
Another factor that is essential for RanGTP-dependent MT nucleation is TPX2 [17] , but this RanGTP-regulated protein was shown to play multiple roles during spindle assembly [18, 19] . Interestingly, TPX2 is a RanGTP-dependent activator of Aurora A [20] [21] [22] [23] . However, the link between this activation and the phosphorylation of NEDD1 by Aurora A has not been established yet. Although TPX2 can nucleate MTs in vitro [24] , experiments performed in Xenopus egg extracts showed that RanGTP-dependent MT nucleation does not occur in the absence of g-tubulin, suggesting that the mechanism at play is far more complex and involves more components in addition to TPX2 [25] . The mechanism by which RanGTP triggers MT nucleation is therefore still unresolved [26] [27] [28] .
Here, we used the Xenopus laevis egg extract system in combination with in vitro experiments to identify the components of the MT nucleation machinery involved in the RanGTP-dependent MT assembly pathway and the mechanism driving its activation in the M-phase cytoplasm.
Results
RanGTP Activates the MT Nucleation Activity of NEDD1-gTuRC To investigate the mechanism by which RanGTP drives MT nucleation in M phase, we used Xenopus laevis egg extracts in which the whole pathway can be triggered by addition of a GTP hydrolysis-deficient form of Ran (RanQ69L) bound to GTP (RanGTP) [29, 30] . Previous data showed that the gTuRC adaptor protein NEDD1 is essential for RanGTP-dependent MT nucleation [13, 16] . To determine whether the association of NEDD1 with the gTuRC is regulated by RanGTP, we immunoprecipitated NEDD1 from extracts in the presence or absence of RanGTP. In both conditions, NEDD1 coimmunoprecipitated the components of the gTuRC XGrip109 (GCP3), g-tubulin, and XGrip195 (GCP6; Figure 1A ). These results suggest that, in extracts, NEDD1 associates with intact gTuRCs in a RanGTP-independent manner. We then addressed the functionality of this complex by examining whether the NEDD1 beads were associated with MTs in the extract. Surprisingly, the NEDD1 beads only generated MT asters in extracts containing RanGTP ( Figures 1B and 1C) . To discriminate between an activation of MT nucleation and an increase of MT stabilization, we retrieved the NEDD1-gTuRC beads from the egg extract and incubated them in pure tubulin ( Figure 1B) . Consistently with our previous result, beads retrieved from a RanGTP-containing egg extract promoted MT assembly whereas those retrieved from a control extract did not (Figure 1D and Figure S1 available online). Altogether, these results indicate that the M-phase egg cytoplasm contains inactive or poorly active NEDD1-gTuRC complexes that become activated through a RanGTP-dependent mechanism.
XRHAMM Defines a Subset of gTuRCs Specifically Involved in RanGTP-Dependent MT Nucleation In addition to NEDD1 and g-tubulin, two proteins, TPX2 and XRHAMM, have been reported to be essential for RanGTPinduced MT assembly [17, 31, 32] . TPX2 has been extensively characterized in the egg extract system, where it was shown that it does not stabilize MTs, thereby suggesting that its role is at the level of MT nucleation [27, 28] . The precise role of RHAMM in the chromosomal pathway is less clear [33, 34] , although recent works also suggested that it plays a role in MT nucleation [32, 35] . To better define this role, we investigated XRHAMM function in RanGTP-dependent MT assembly using the Xenopus egg extract system.
As previously shown, the gTuRC components XGrip109 and g-tubulin coimmunoprecipitated with XRHAMM in egg extract ( Figure 2A ) [32] . In addition, we also detected NEDD1 and XGrip195 in the immunoprecipitation, suggesting that XRHAMM interacts with the full gTuRC ( Figure 2A ). Interestingly, these interactions were not regulated by RanGTP (Figure 2A ), suggesting that the mitotic Xenopus egg extract contains a stable XRHAMM-NEDD1-gTuRC complex. To determine whether this complex is in fact a general MT nucleation complex in egg extracts, we monitored MT nucleation by the sperm-associated immature centrosome upon incubation in egg extracts depleted for either NEDD1, TPX2, or XRHAMM (Figures 2B and S2) [36] . As expected, MT nucleation at the centrosome was strongly impaired in NEDD1-depleted extract. In contrast, centrosomal MT nucleation was as efficient in XRHAMM or TPX2-depleted extracts as in control extracts ( Figure 2B ). These results strongly indicated that XRHAMM and TPX2 are not required for MT nucleation at the centrosome, suggesting that their function is specific for the RanGTP pathway.
Altogether, our data show that XRHAMM forms a complex with NEDD1-gTuRC not directly regulated by RanGTP that is not involved in centrosomal-regulated MT nucleation.
RanGTP Promotes the Interaction between TPX2
and the RHAMM-NEDD1-gTuRC Complex It was previously reported that XRHAMM coimmunoprecipitates with TPX2 in a RanGTP-independent manner [32] . Using our anti-XRHAMM or anti-TPX2 antibodies, we found that XRHAMM and TPX2 coimmunoprecipitate in a RanGTPdependent way in egg extracts ( Figure 3A ). To determine whether the two proteins interact directly, we performed pulldowns in vitro using recombinant GFP-TPX2 and a His-tagged C-terminal fragment of XRHAMM (137 last amino acids: 1,038-1,175). As shown in Figure 3B , anti-GFP antibodies pulled down both proteins, indicating that TPX2 interacts directly with the C-terminal region of XRHAMM ( Figures 3B and S3 ). These results suggested that RanGTP promotes the direct interaction between its target TPX2 and XRHAMM. Because XRHAMM interacts with the gTuRC (Figure 2A ) [32] , we then tested whether TPX2 coimmunoprecipitated with the gTuRC. Indeed, we found that TPX2 coimmunoprecipitated with NEDD1 and g-tubulin in a RanGTP-dependent manner ( Figure 3C ). We then tested whether this interaction was XRHAMM dependent. We found that in XRHAMM-depleted extracts, TPX2 did not coimmunoprecipitate with NEDD1 ( Figure 3D ). Therefore, our data strongly suggest that RanGTP induces a specific direct interaction between TPX2 and XRHAMM, triggering the formation of a TPX2-XRHAMM-NEDD1-gTuRC supracomplex.
We then examined whether this supracomplex is specifically required for the RanGTP-dependent MT nucleation pathway. Anti-NEDD1-coated beads were incubated in control or XRHAMM or TPX2-depleted extracts with or without RanGTP, retrieved from the extracts, washed, and their MT nucleation activity tested in pure tubulin ( Figure 3E ). As determined by western blot analysis, the NEDD1 beads carried g-tubulin in all conditions ( Figure 3D ). In agreement with our previous results, the NEDD1 beads retrieved from extract containing RanGTP triggered MT nucleation in vitro. However, NEDD1 beads retrieved from XRHAMM-or TPX2-depleted extracts containing RanGTP did not trigger MT assembly in pure tubulin ( Figure 3E) .
We conclude that, by promoting a direct interaction between TPX2 and XRHAMM, RanGTP induces the formation of an active MT nucleation supracomplex. However, the specific function of TPX2 in the activation of MT nucleation is unclear.
The Essential Phosphorylation of NEDD1 on S405 Requires TPX2-Dependent Aurora A Activation RanGTP promotes the interaction of TPX2 with Aurora A, leading to its activation [20] [21] [22] [23] , and we recently showed that NEDD1 phosphorylation by Aurora A is essential for RanGTP-dependent MT assembly [16] . Consistently, we found that NEDD1 interaction with Aurora A is strongly enhanced by RanGTP ( Figure 4A ). This suggested that, by promoting the interaction of TPX2 with the gTuRC, RanGTP could indirectly favor the phosphorylation of NEDD1 by Aurora A on S405. To explore this possibility, we took advantage of the RanGTPindependent activity of a recombinant TPX2 protein mutated in its NLS (TPX2-DNLS) ( Figures 4B and S4A ). This protein promotes MT nucleation and activates Aurora A in the absence of RanGTP [24, 37] . Egg extracts were codepleted for TPX2 and NEDD1. Addition of either NEDD1 wild-type (WT) or any of its phospho-variants, NEDD1-S405A (unphosphorylable) or NEDD1-S405D (phospho-mimicking) [16] did not promote MT nucleation ( Figure S4B ). As previously described, TPX2-DNLS did promote MT aster formation in egg extracts in a RanGTPindependent way [24] . Interestingly, this activity was strictly dependent on NEDD1 and, in agreement with our previous data, on its phosphorylation on S405 ( Figure 4C ) [16] . These results show that TPX2 is the only factor that needs to be directly regulated by RanGTP to trigger MT assembly. They also show that TPX2 cannot induce MT nucleation directly in egg extract as it does in vitro [24] but functions through a mechanism that involves NEDD1 and its phosphorylation on S405. Because TPX2-DNLS interacts with and activates Aurora A in a RanGTP-independent manner, this suggests that the main mechanism by which TPX2 triggers MT nucleation is by promoting NEDD1 phosphorylation by Aurora A.
To gain additional support for this idea, we monitored MT aster formation in TPX2 and NEDD1-depleted egg extracts upon addition of another form of TPX2DNLS lacking the first 39 amino acids (D39TPX2DNLS) ( Figure 4B ) and therefore unable to activate Aurora A [20] . MT assembly did not occur in depleted extracts complemented with D39TPX2DNLS and either NEDD1-WT or NEDD1-S405A. However, addition of the phospho-mimicking NEDD1-S405D restored MT assembly (Figures 4D , S4A, and S4B). These data strongly suggested that MT nucleation involves the TPX2-dependent Aurora A activation that promotes the essential phosphorylation of NEDD1 on S405. Because NEDD1-S405D is sufficient for MT nucleation in the absence of active Aurora A, our results also indicate that NEDD1 S405 is the only Aurora A target essential for the RanGTP-dependent MT nucleation. Moreover, this critical phosphorylation is also specific for the RanGTP pathway, as it does not interfere with MT nucleation at the centrosome ( Figure S5A ).
To explore the role of NEDD1 S405 phosphorylation by Aurora A, we then examined whether it could regulate the interaction of NEDD1 with the gTuRC. Pull-down experiments using the three phospho-variants of NEDD1 in egg extract did not provide any evidence for a differential phospho-dependent binding activity of NEDD1 to the gTuRC components (Figure S5B ). We then decided to explore the possibility that NEDD1 phosphorylation could promote the recruitment of one or more additional factors required for the activation of the MT nucleation complex. NEDD1 beads were retrieved from egg extract in the absence of RanGTP. As reported above, these beads do not carry TPX2 or Aurora A and they do not trigger MT nucleation in pure tubulin. The beads were incubated in vitro with Aurora A in the presence or absence of ATP and placed in pure tubulin to test their activity ( Figure 4E ). Strikingly, the NEDD1 beads incubated with Aurora A and ATP efficiently promoted MT nucleation in pure tubulin ( Figure 4E ), whereas those incubated without ATP did not (data not shown). These results indicate that all the proteins required for MT nucleation are recruited on the NEDD1 beads retrieved from egg extract in the absence of RanGTP. However, to be active in MT nucleation, this complex requires the phosphorylation of one or more of its components by Aurora A. Our data strongly suggest that the critical substrate of Aurora A is NEDD1.
In Addition to Aurora A Activation, TPX2 Provides Another Essential Function for RanGTP-Dependent MT Nucleation through the Recruitment of gTuRCs Our results suggested that the activation of Aurora A by TPX2 could be sufficient for triggering MT nucleation in the egg extract. We therefore decided to test experimentally this idea. Addition of the phospho-mimicking NEDD1-S405D to a NEDD1-depleted extract in the absence of RanGTP did not promote MT aster formation ( Figure 5A ). Consistently, the addition of TPX2-N39 that is sufficient to fully activate Aurora A in egg extract did not promote MT assembly either ( Figure 5B ). These results indicated that, although the phosphorylation of NEDD1 S405 by Aurora A is essential, it is not sufficient to trigger MT nucleation, suggesting that TPX2 has additional functions in the pathway that go beyond Aurora A activation.
All our previous experiments showing that NEDD1 phosphorylation was essential and sufficient to trigger MT nucleation in extract without RanGTP and in vitro were performed using NEDD1 beads. We therefore hypothesized that, under physiological conditions, TPX2 could provide a similar recruitment or scaffolding activity. To test this idea, we repeated the same experiments as above (Figures 5A and 5B) but using the NEDD1 phospho-variants loaded on beads. The beads were retrieved from the extract and their MT nucleation capacity tested in pure tubulin. As described above, the NEDD1-WT beads nucleated MTs only when retrieved from an extract containing RanGTP ( Figures 1D and 5C ) whereas the NEDD1-S405A beads did not promote MT nucleation in any condition ( Figure 5C ). In contrast, the NEDD1-S405D beads did trigger MT nucleation in a RanGTP-independent manner ( Figure 5C ). Western blot analysis showed that the NEDD1-S405D beads associated with gTuRC components, but not with TPX2 and Aurora A in absence of RanGTP ( Figure S5B ). Therefore, these results suggest that NEDD1 phosphorylation on S405 alone is sufficient for triggering MT nucleation in the absence of RanGTP as long as the nucleation complex is recruited onto a scaffolding element (here provided by beads). In further support of this idea, NEDD1 beads retrieved from a TPX2-depleted extract containing the Aurora-A-activating fragment TPX2-N39 triggered MT nucleation in pure tubulin independently of RanGTP ( Figure 5D ). Altogether, our data show that, in addition to Aurora A activation, TPX2 provides another essential activity that can be recapitulated by recruiting the nucleation complex on beads.
TPX2 Has Oligomerization Properties that May Be Regulated by RanGTP
To gain some insights into how TPX2 may provide the putative scaffolding activity, we first explored whether TPX2 may form oligomers in vitro. Pull-downs performed in vitro with anti-GFP antibodies on a mixture of GFP-TPX2 (GFP-TPX2) and His-D39-TPX2 showed that both proteins interact, indicating that TPX2 can oligomerize in vitro ( Figure 6A ). To test whether TPX2 may also oligomerize under physiological conditions, we performed pull-downs with anti-GFP antibodies in egg extracts containing either GFP-TPX2 (GFP-TPX2) or a shorter C-terminal fragment (GFP-TPX2-CT). In addition, the extracts were supplemented or not with RanGTP. Both recombinant TPX2 proteins pulled down endogenous TPX2 but strikingly only in extracts supplemented with RanGTP ( Figure 6B ). These results indicated that TPX2 may oligomerize in the M-phase egg extract, and interestingly, this property is regulated by RanGTP. Moreover, our results indicate that this property is mediated by TPX2 C-terminal region ( Figure 6B ). These data suggest that RanGTP-dependent TPX2 oligomerization may facilitate the recruitment of the MT nucleation complexes required for efficient MT nucleation.
Altogether, our data support a model in which the release of TPX2 from the importins triggered by RanGTP promotes two Three independent experiments were performed, counting more than 500 beads in each condition. Error bars: SD. ***p < 0.001% using X-squared test. The scale bars represent 10 mm.
essential events: (1) the recruitment of RHAMM-gTuRC complexes through the direct interaction between TPX2 and XRHAMM and TPX2 oligomerization and (2) a TPX2-dependent activation of Aurora A that promotes the phosphorylation of NEDD1 on S405. We propose that this series of connected events is at the basis of the mechanism that drives RanGTPdependent MT nucleation in M phase ( Figure 6C ).
Discussion
The gTuRC is the multiprotein complex that drives MT nucleation in higher animal cells. Its spatial and temporal regulation determines where and when this important process occurs in the cell, determining MT organization and cell function. During cell division, MT nucleation occurs through different pathways, all of them depending on the gTuRC. One of them is triggered by the chromosomes that generate a gradient of RanGTP that promotes local MT nucleation, stabilization, and organization. The chromosome/ RanGTP-dependent MTs are essential for spindle formation and function both when centrosomes are present or not. Here, we uncovered the mechanism by which RanGTP triggers the activation of MT nucleation by the gTuRC.
Previous reports suggested that the gTuRCs obtained from cells or egg extracts have an intrinsic MT nucleation activity [38, 39] . However, here, we showed that the gTuRCs pulled down from Xenopus egg extracts through NEDD1 did not promote MT nucleation in extract or in vitro unless activated by a RanGTP-dependent mechanism. These apparently contradictory results may be due to differences in the composition of the complexes as a result of the precise experimental conditions that could either alter their composition or regulation. Our data in fact suggest that the M-phase cytoplasm of the egg contains different gTuRC subcomplexes having a common set of components and additional associated protein(s). One of them, including RHAMM, is the target for regulation by RanGTP.
Previous work reported that g-tubulin and GCP3 coimmunoprecipitated with XRHAMM in egg extract [32] . Here, we showed that this complex also includes GCP6, suggesting that it corresponds to the full gTuRC. Because depletion of XRHAMM leaves almost intact levels of g-tubulin and gTuRC components in the egg extract ( Figures 3D and S2) , this indicates that a large pool of gTuRCs is in fact not associated with XRHAMM. Accordingly, we found that depleting XRHAMM from the egg extract did not compromise the capacity of centrosomes to nucleate MTs ( Figure 2B ). These data therefore suggest that the M-phase cytoplasm contains different complexes of gTuRCs that may potentially have specific roles in the different MT nucleation pathways.
Because XRHAMM and TPX2 interact directly, this strongly suggests that the RHAMM-associated gTuRC complex is the specific target of RanGTP-dependent regulation. Indeed, our data show that RanGTP promotes the interaction between its direct target TPX2 and XRHAMM, itself associated with the MT nucleation complex, suggesting that this is the primary mechanism for the RanGTP-dependent activation of MT nucleation. Groen and collaborators had previously reported that TPX2 and XRHAMM coimmunoprecipitated in egg extract in a RanGTP-independent manner [32] , although they discussed that this could be due to antibody effects. Here, we found that our anti-XRHAMM and anti-TPX2 antibodies were efficient in coimmunoprecipitating the two proteins but only in extracts containing RanGTP. The identical results obtained with two different antibodies strengthen our conclusion. Moreover, in line with this conclusion, we showed that the RanGTPdependent interaction of TPX2 with the NEDD1-gTuRC complex requires XRHAMM. Error bars: SD. ***p < 0.001% using X-squared test.
(B) MT assembly in TPX2-depleted extracts complemented with TPX2 full length (control) or TPX2-N39 (as indicated) with or without RanGTP. The experimental design is shown at the top. The graph shows the number of asters per microliter of extract in three independent experiments. Error bars: SD. ***p < 0.001% using X-squared test. ns, nonsignificant. (C) MT nucleation in pure tubulin around beads coated with Flag-NEDD1 phospho-variants retrieved from NEDD1-depleted extract containing or not RanGTP. The experimental design is shown at the top. The graph shows the percentage of beads associated with MTs. Data from three independent experiments. More than 500 beads were counted for each condition. Error bars: SD. ***p < 0.001% using X-squared test. (D) MT nucleation in pure tubulin around NEDD1-coated beads retrieved from control or TPX2-depleted extract containing or not RanGTP. The depleted extract was supplemented or not withTPX2 full length (control) and TPX2-N39, as indicated. The experimental design is shown at the top. The graph shows the percentage of beads associated with MTs. Data from three independent experiments. More than 500 beads were counted for each condition. Error bars: SD. ***p < 0.001% using X-squared test.
Our work shows that one of the essential functional implications of the RanGTP-dependent association of TPX2 with the RHAMM-gTuRC complex is the phosphorylation of NEDD1 on S405 by the TPX2-activated Aurora A. Indeed, all the different approaches we used unequivocally show that this phosphorylation event is essential for this pathway. In particular, we found that the MT nucleation activity of NEDD1 beads could be fully restored in the absence of TPX2 by promoting or mimicking NEDD1 phosphorylation. Moreover, because we found that the requirement for active Aurora A can be substituted by the phospho-mimicking form of NEDD1, our data also suggest very strongly that NEDD1 is the only Aurora A substrate that is essential for MT nucleation in this pathway. Consistently with our findings, a recent study correlates RHAMM, TPX2, and Aurora A activity in mammalian cells [35] .
We still do not know the precise role of NEDD1 phosphorylation on S405 by Aurora A. One possibility is that phosphorylation triggers a conformational change of the complex. This idea is based on previous work suggesting that a relative flexibility of the gTuRC could define inactive versus active template gTuRC complexes [9] . Another nonexclusive possibility is that phosphorylation regulates a protein-protein interaction. However, the pull-down experiments we performed with the various phospho forms of NEDD1 did not reveal any change in the interactions with the gTuRC components. In addition, because we found that the in vitro phosphorylation of the complex by Aurora A is sufficient to activate it ( Figure 4E ), the recruitment of an additional factor is very unlikely. At present, we cannot rule out that NEDD1 phosphorylation may promote the release of an inhibitory factor. Additional work will be required to elucidate the molecular consequences of NEDD1 phosphorylation by Aurora A for the activation of RanGTPdependent MT nucleation.
It is interesting to note that NEDD1 is highly phosphorylated in mitosis [40] and that the three M-phase MT nucleation pathways require each a specific phosphorylation of NEDD1 by a different kinase on residues that are all in close proximity (S377, 411, and 405) [13, 14, 41] . It is therefore tempting to speculate that this region of NEDD1 has essential features for the activation of MT nucleation by the gTuRC.
Our work also provides a compelling evidence for an additional function of TPX2 in RanGTP-dependent MT nucleation in addition to the activation of Aurora A. Indeed, the essential phosphorylation of NEDD1 is not sufficient for triggering MT nucleation in the absence of TPX2. We found, however, that recruiting phosphorylated NEDD1-gTuRC complexes on beads was sufficient to substitute for TPX2. Because we found that TPX2 can form oligomers in vitro and that RanGTP promotes the formation of complexes with various TPX2 molecules, we propose that TPX2 provides a scaffolding role to recruit various nucleation complexes favoring their activation. The fact that NEDD1 beads are active suggests that the mechanism does not require a very specific spatial configuration. In any case, it is interesting to note that NEDD1 phosphorylation and gTuRC recruitment seem to represent two common events required for the activation of MT nucleation in the different MT nucleation pathways.
In agreement with previous reports [24, 37] , we show that a mutated form of TPX2 that does not bind importins promotes MT nucleation in the absence of RanGTP. Under these conditions, TPX2 provides the two essential requirements that we have identified in this work: it promotes NEDD1 phosphorylation through Aurora A activation and it acts as a recruitment factor for the MT nucleation complex. As this occurs in the absence of RanGTP, we conclude that TPX2 is the only direct target of RanGTP required for MT nucleation through this pathway, although this does not rule out essential roles for other RanGTP targets in the complete pathway of MT assembly and organization [1] . Although other RanGTP-regulated proteins have been proposed to participate in MT nucleation [42] , it still remains to be established at which level these proteins may function.
Recently, it was proposed that augmin, g-tubulin, and TPX2 work in complex in branching MT nucleation, linking the RanGTP and the augmin-dependent MT nucleation pathways [43] . The augmin pathway is a MT-amplification pathway and relies on the presence of preexisting MTs [44, 45] . Consistently, augmin depletion does not abolish MT assembly induced by RanGTP or chromatin beads in egg extracts [46] . In contrast, TPX2 depletion prevents altogether RanGTP-or chromatin-beads-induced MT assembly [26, 37] , suggesting that the augmin pathway acts downstream of the RanGTP-TPX2 pathway. Here, we focused on understanding how RanGTP promotes MT nucleation and found that it functions by promoting a specific interaction of TPX2 with the gTuRC. Further work is needed to establish how the two pathways may be functionally connected.
In conclusion, our work provides the first integrated picture for the mechanism by which RanGTP triggers MT nucleation in M phase. RanGTP induces the interaction between a preformed, dedicated RHAMM-gTuRC complex with TPX2. Within this new complex, TPX2 provides two essential requirements for MT nucleation: the activation of Aurora A promoting the NEDD1phosphorylation on S405 and a scaffolding activity for the recruitment of the MT nucleation complex. TPX2 is therefore the central player of the RanGTP-dependent gTuRC activation mechanism, leading to MT nucleation around the chromosomes in mitosis.
Experimental Procedures DNA Constructs, Expression, and Purification of Recombinant Proteins All hNEDD1 constructs and protein expression and purification methods were previously described [16] . The constructs for TPX2DNLS, D39TPX2DNLS, GST-N39 TPX2, and TPX2-CT and the methods for protein expression and purification were previously described [20, 37] . His-D39TPX2 was prepared cloning 1-39 deleted TPX2 in pHAT-2 vector. His-XRHAMM CT was prepared cloning a C-terminal fragment (last 137 amino acids) of the Xenopus laevis protein into pET-28a vector (Novagen). His-Aurora A was cloned and purified as described previously [21] . 
Antibodies
The rabbit polyclonal antibodies against Xenopus TPX2 and Xenopus NEDD1 were previously described [14, 17] . The mouse monoclonal antibody anti-Xenopus TPX2 was raised by Abyntek Biopharma using the full-length protein and recognizes an N-terminal epitope. The rabbit polyclonal antibody against Xenopus RHAMM was raised against a GST-RHAMM-CT (corresponding to the last 137 amino acids) and affinity purified. The mouse 1C1 monoclonal antibody against Xenopus Eg2 (Aurora A) was a kind gift from Claude Prigent (CNRS Université de Rennes). Polyclonal antibodies against XGrip195 and XGrip109 were kind gifts from Yixian Zheng (Carnegie Institution for Science).
The following commercial antibodies were used: a monoclonal mouse antibody against g-tubulin (GTU-88; Sigma-Aldrich); a monoclonal antihuman NEDD1 (that cross-reacts with Xenopus laevis NEDD1; Abcam); a mouse monoclonal anti-tubulin (12G10; Developmental Studies Hybridoma Bank) [47] ; and the monoclonal mouse antibody against tubulin (DM1A; Sigma-Aldrich).
Secondary antibodies were anti-rabbit or anti-mouse conjugated to Alexa 488, Alexa Fluor 568, or Alexa Fluor 680 (Life Technologies) and were used at 1:1,000 for immunofluorescence and 1:10,000 for western blot.
Immunofluorescence and Microscopy
All samples were visualized with a 340 or 363 objective on an inverted DMI-6000 Leica wide-field fluorescent microscope equipped with a Leica DFC 350FX camera. Spins down of NEDD1 beads were processed for immunofluorescence with anti-tubulin 12G10. Coverslips were fixed in methanol and mounted in Mowiol (Calbiochem).
All pictures were acquired with the Leica Application Suite software. Images were processed with ImageJ or Photoshop (Adobe) and mounted using Photoshop (Adobe).
Xenopus laevis Egg Extract
All work involving animals was done according to standard protocols approved by the Centre for Genomic Regulation Ethics Committee. Cytostatic-factor-arrested egg extracts from Xenopus laevis were prepared as previously described [48] . Recombinant RanQ69LGTP was expressed and purified as previously described [37] .
RanGTP asters were induced by adding 15 mM of RanQ69L-GTP to egg extracts containing 0.2 mg/ml of rhodamine-labeled tubulin. Extracts were incubated at 20 C, and squashes of 3 ml were collected at the indicated time points. Quantifications were made counting the total number of MT asters in ten random lines for each coverslip (403 magnification with Leica DMI6000B microscope equipped with a Leica DFC 350FX camera). Data were normalized to obtain the number of aster per microliter of extract.
Centrosome MT assembly was studied adding demembranated Xenopus sperm nuclei at a concentration of w500 nuclei/ml to egg extracts containing 0.2 mg/ml of rhodamine-labeled tubulin. Extracts were incubated at 20 C, and squashes of 3 ml were collected after 6, 8, and 10 min of incubation. MT nucleation from sperm centrosomes was evaluated counting 100 nuclei for each condition.
Immunodepletions and Immunoprecipitations
For NEDD1, TPX2, and XRHAMM immunodepletions, one volume of antibody-coated protein A Dynabeads (Life Technologies) was incubated in 2.5 volumes of egg extract. Dynabeads were prepared following manufacturer's recommendations. Two rounds of immunodepletion of 30 min each at 4 C completely depleted the endogenous proteins from the egg extract. Mock control depletions were performed in the same conditions using unspecific anti-rabbit immunoglobulin G (IgG)-coated protein A Dynabeads. After immunodepletions, RanGTP or buffer was added to the extract for 15 min at 20 C. Add backs of NEDD1, NEDD1 phosphovariants, TPX2-DNLS, and D39TPX2DNLS were performed as previously described [16, 20, 37] . TPX2-N39 was added to the egg extract as previously described [21] .
For immunoprecipitations, one volume of protein A Dynabeads (Life Technologies) was coated with the indicated antibodies (6 mg for 20 ml of beads) and incubated for 1 hr on ice in 2.5 volumes of colony-stimulating factor (CSF)-arrested extract. For detection of NEDD1-XRHAMM, NEDD1-TPX2, and XRHAMM-TPX2 interactions, beads were washed without detergent (four times in Tris-buffered saline [TBS] ). For all the other immunoprecipitations, beads were washed in TBS 0.1% Triton X-100. Proteins were eluted from beads directly in SDS-PAGE loading buffer 23. All the immunoprecipitations were performed in egg extract previously incubated for 15 min at 20 C with RanGTP or CSF-XB buffer (10 mM HEPES [pH 7.7], 50 mM sucrose, 100 mM KCl, 0.1 mM CaCl2, and 5 mM EGTA).
In Vitro Pull-Downs For in vitro pull-down experiments, recombinant proteins were incubated in PBS for 20 min at 20 C. Anti-GFP immunoprecipitation was then performed using protein A Dynabeads (Life Technologies). Beads were washed four times in PBS Triton X-100 0.1% and directly eluted in loading buffer. For better detection of interaction, SDS-PAGE was stained using colloidal blue (Invitrogen).
Bead Experiments
To assay the gTuRC MT nucleation activity, beads coated with anti-NEDD1 antibodies were incubated in egg extract. For analyzing the MT nucleation activity of NEDD1 phospho-variants, NEDD1-depleted egg extracts were complemented with the corresponding recombinant proteins for 20 min at 20 C. The NEDD1 variants and associated proteins were then recovered with anti-NEDD1 antibody-coated beads. So that the role of NEDD1 S405 phosphorylation in vitro could be studied, NEDD1 beads were retrieved from the egg extract and incubated in kinase buffer (8 mM 3-(N-morpholino)propanesulfonic acid, 20 mM MgCl 2 , 0.2 mM EDTA, and 5% glycerol) with recombinant His-tagged Xenopus Aurora A (0.2 mM), TPX2-N39 (0.2 mM), and ATP (4 mM).
To evaluate MT nucleation in egg extract, beads were washed four times in CSF-XB buffer (10 mM HEPES [pH 7.7], 50 mM sucrose, 100 mM KCl, 0.1 mM CaCl2, and 5 mM EGTA) and then resuspended in the same initial volume of beads. Beads were then diluted 200-400 times in 20 ml CSFarrested extract and incubated at 20 C for 20-30 min, depending on the extract.
To study MT nucleation in vitro, beads were washed twice in CSF-XB, twice in BRB80 (80 mM PIPES [pH 6.8], 1 mM EGTA, and 1 mM MgCl2), and resuspended in the same initial volume in BRB80. One to two microliters of beads were then added to a 30 mM pure tubulin solution and incubated for 10 min at 37 C. For both approaches, the reaction mixture was fixed in 1% glutaraldehyde (in BRB80), spun down through a 10% glycerol in BRB80 cushion onto a coverslip, and fixed in methanol for 10 min at 220 C. MTs were then visualized by immunofluorescence using anti-tubulin antibody. The quantifications were performed by evaluating the proportion of beads associated with MTs in 30 random fields for each condition.
Supplemental Information
Supplemental Information includes five figures and can be found with this article online at http://dx.doi.org/10.1016/j.cub.2014.11.025.
Author Contributions
I.V., S.M., and J.S. designed the experiments. J.S. performed all the experiments except the TPX2-TPX2 interaction in egg extract, done by T.S. I.V., S.M., and J.S. analyzed the data and wrote the manuscript.
